Despite concerns, the forecast for sales of branded drug Austedo remain unchanged even though the US Inflation Reduction Act (IRA) aims to cut pharmaceutical prices.
Teva beats analysts on Q3, raises guidance
Despite concerns, the forecast for sales of branded drug Austedo remain unchanged even though the US Inflation Reduction Act (IRA) aims to cut pharmaceutical prices.